Litcius/Paper detail

CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma

Beatriz Salvador-Barberó, Mónica Álvarez‐Fernández, Elisabet Zapatero‐Solana, Aicha El Bakkali, María del Camino Menéndez, Pedro P. López‐Casas, Tomás Di Domenico, Tao Xie, Todd VanArsdale, David J. Shields, Manuel Hidalgo, Marcos Malumbres

2020Cancer Cell180 citationsDOIOpen Access PDF

Topics & Concepts

Cytotoxic T cellChemotherapyCancer researchAdenocarcinomaPancreatic cancerBiologyPharmacologyMedicineInternal medicineCancerIn vitroGeneticsAdvanced Breast Cancer TherapiesCancer-related cognitive impairment studiesPancreatic and Hepatic Oncology Research
CDK4/6 Inhibitors Impair Recovery from Cytotoxic Chemotherapy in Pancreatic Adenocarcinoma | Litcius